Actionnariat et activité des initiés pour Dyne Therapeutics, Inc. (DYN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $17.30 |
| Capitalisation | $3.2B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-04 | Friedl-Naderer Johanna | S-Sale | 900 | $22K |
| 2026-09-08 | Friedl-Naderer Johanna | S-Sale | 185 | $3K |
| 2026-09-04 | Kerr Douglas | S-Sale | 3,745 | $91K |
| 2026-09-08 | Kerr Douglas | S-Sale | 1,290 | $24K |
| 2026-09-08 | Cox John | S-Sale | 5,658 | $107K |
| 2026-08-13 | Rhodes Jason P | S-Sale | 268,354 | $7.0M |
| 2026-08-14 | Rhodes Jason P | S-Sale | 1,359,674 | $34.0M |
| 2026-08-13 | Rhodes Jason P | S-Sale | 94,415 | $2.5M |
| 2026-08-13 | Rhodes Jason P | S-Sale | 63,643 | $1.7M |
| 2026-08-14 | Rhodes Jason P | S-Sale | 478,377 | $12.0M |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.78B | $365.0M | $8.1M | $14.6M | $300.9M | $200.8M | $172.1M | $121.6M | $435.4M | $893.4M |
| Placements à Court Terme | $130.0M | $32.0M | 0 | 0 | $44.5M | $175.7M | $83.9M | $1.5M | $206.8M | $217.2M |
| Créances | $386.0M | $513.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | $445.0M | $445.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $2.99B | $1.52B | $8.2M | $14.8M | $349.1M | $382.4M | $265.6M | $129.4M | $659.3M | $1.13B |
| Immobilisations Corporelles | $7.12B | $8.88B | $110000 | $1.5M | $1.9M | $41.0M | $38.4M | $33.4M | $30.0M | $44.8M |
| Goodwill | $799.0M | $772.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $38.0M | $25.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $13.05B | $11.77B | $8.3M | $16.4M | $353.3M | $425.7M | $306.3M | $165.1M | $691.2M | $1.19B |
| Dettes Fournisseurs | $332.0M | $367.0M | $518000 | $1.3M | $3.4M | $4.0M | $5.3M | $22.9M | $6.6M | $8.1M |
| Dette à Court Terme | $201.0M | $105.0M | 0 | 0 | 0 | 0 | 0 | 0 | $4.8M | $5.0M |
| Passifs Courants | $916.0M | $1.05B | $711000 | $2.4M | $11.0M | $28.7M | $28.1M | $51.1M | $42.3M | $50.6M |
| Dette à Long Terme | $8.78B | $8.33B | $3.4M | 0 | 0 | 0 | 0 | 0 | 0 | $15.3M |
| Passifs Totaux | $11.01B | $9.87B | $13.1M | $2.4M | $11.0M | $57.5M | $54.0M | $73.8M | $61.4M | $214.8M |
| Réserves | -$1.93B | -$1.85B | -$4.9M | -$19.7M | -$79.2M | -$228.5M | -$396.6M | -$632.5M | -$949.9M | -$1.40B |
| Capitaux Propres | $2.04B | $1.90B | -$4.9M | $14.0M | $342.4M | $368.2M | $252.4M | $91.3M | $629.8M | $972.1M |
| Dette Totale | $8.98B | $8.43B | $3.4M | 0 | 0 | $32.6M | $30.5M | $27.4M | $24.0M | $20.3M |
| Dette Nette | $7.07B | $8.04B | -$4.7M | -$14.6M | -$345.3M | -$343.9M | -$225.5M | -$95.7M | -$618.3M | -$1.09B |
| Fonds de Roulement | $2.07B | $475.0M | $7.4M | $12.4M | $338.1M | $353.7M | $237.5M | $78.3M | $617.0M | $1.08B |
Santé financière
| Dette / Capitaux propres | 0.03 |
| Ratio de liquidité | 12.02 |
Rentabilité
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: AAPG · APGE · CELC · CGON · CNTA · MIRM · RARE
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DYN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions